Research and Markets: Gain an Insight into the Latest Trends and Events Impacting the Pharmaceutical Company - Johnson & Johnson.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c37459) has announced the addition of the Espicom Business Intelligence Introduction Espicom Business Intelligence is a publisher of independent and impartial information and analysis services focusing on the pharmaceutical and medical device markets. Ltd report: Johnson & Johnson Pharmaceutical Company Intelligence Report to their offering Pharmaceutical company intelligence reports provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance is covered in-depth, from its latest results to a complete analysis of its latest full fiscal year and an outlook for the future. A section on company strategy covers mergers, acquisitions and divestitures, key agreements, products and R&D. An overview of key products and R&D is followed by a comprehensive review of the company's product portfolio and research and development pipeline by therapeutic area. In addition, supplementary appendices provide more in-depth information on financials, agreements and corporate events. Summary Johnson & Johnson's operating activities are conducted within three business segments: Medical Devices & Diagnostics, Pharmaceutical and Consumer. This report provides a full review of the company's pharmaceutical activities. Johnson & Johnson, through more than 230 operating companies, manufactures and sells a broad range of products in the healthcare field for the pharmaceutical, consumer, and medical devices and diagnostic markets to most countries of the world. The company is organised on the principles of decentralised Adj. 1. decentralised - withdrawn from a center or place of concentration; especially having power or function dispersed from a central to local authorities; "a decentralized school administration" decentralized management. Current Growth Drivers Within the Pharmaceutical segment in 2005, strong sales performances were demonstrated by Risperdal and Risperdal Consta, Remicade, Topamax and Levaquin. Key Late-Stage Products Virology virology, study of viruses and their role in disease. Many viruses, such as animal RNA viruses and viruses that infect bacteria, or bacteriophages, have become useful laboratory tools in genetic studies and in work on the cellular metabolic control of gene expression is a relatively new area of focus for J&J and it is currently developing three HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. compounds of which TMC TMC Technology Marketing Corporation (Norwalk, Connecticut) TMC Texas Medical Center (Houston, TX) TMC Traffic Message Channel TMC The Movie Channel TMC Traffic Management Center 114, the most advanced compound, has been filed. Candidates in Phase III Noun 1. phase III - a large clinical trial of a treatment or drug that in phase I and phase II has been shown to be efficacious with tolerable side effects; after successful conclusion of these clinical trials it will receive formal approval from the FDA trials include: Ceftobiprole for complicated skin and skin structure infections and nosocomial pneumonia nosocomial pneumonia An infection of lungs–bronchoalveolar unit–in a Pt who has been hospitalized ≥ 48 hrs, and directly attributable to pathogens acquired during the hospital visit Etiology Pseudomonas spp, S aureus, Legionella . Both indications have been granted fast track designation by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. . Doripenem, a broad-spectrum antibiotic for complicated urinary tract infections urinary tract infection (UTI), n infection in one or more of the structures that make up the urinary system. Occurs more often in women and is most commonly caused by bacteria. , complicated intra-abdominal infections and nosocomial pneumonia. BAY 59-7939 (Factor Xa inhibitor) for venous thromboembolism thromboembolism /throm·bo·em·bo·lism/ (-em´bo-lizm) obstruction of a blood vessel with thrombotic material carried by the blood from the site of origin to plug another vessel. throm·bo·em·bo·lism n. prevention after major orthopaedic surgery (hip and knee). This company report provides Latest Results A brief review of the latest report results Executive Summary At a glance understanding of the major trends and events affecting the company Financial Analysis (current year) Detailed P&L and investment review of the latest full year performance Company Strategy Where's the company going and how does it plan getting there? Product/R&D Pipeline Highly detailed monographs organised by therapeutic category. Also covers R&D strategy/pipeline and provides 5-year sales forecasts to 2010 for major launched products where available Appendices 5-year financial assessment Key corporate events Key agreements Infrastructure Major pharmaceutical subsidiaries/joint ventures Product index Companies Mentioned Include: - Ablynx - AdipoGenix Inc - Amgen - Arena Pharmaceuticals Inc - Barrier Therapeutics - Basilea Pharmaceutica AG - Bayer - Biovail Corporation International - Cara Therapeutics Inc - Cellzome Inc - Crucell NV - Curis Inc - Eisai - Eli Lilly - Entelos Inc - Ferring Pharmaceuticals Inc - GlaxoSmithKline - GTx Inc - Icagen Inc - ImClone Systems Inc - ImmunoGen Inc - Kyowa Hakko - Medivir AB - Mitsubishi Pharma Corporation - Millennium Pharmaceuticals Inc - Morphosys - Mylan Pharmaceuticals Inc - Neurochem Inc - Paradigm Therapeutics Ltd - Pamgene International BV - Pharmaceutical Product Development Inc (PPD (1) (Parallel Presence Detect) The method used by earlier SIMM memory modules to communicate their capacity to the computer. A binary number coming from a parallel set of pins was read by the system, with each pin representing one bit. Contrast with SPD. ) - Roche/Dade Behring - Sangamo BioSciences Inc - Sepracor Inc - Serono - Shire Pharmaceuticals/Synaptec Inc - Taisho Pharmaceutical Co Ltd - Zeltia Group For more information visit http://www.researchandmarkets.com/reports/c37459 |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion